SUFLAVE FDA approval date

The FDA approved SUFLAVE on 15 Jun 2023.

FDA approval date
15 Jun 2023

Drug identity has not yet been verified against registry records

Also recorded as MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM SULFATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-06-15DaySUFLAVEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215344", "applicant_as_listed_by_fda": "AZURITY", "brand_names": ["SUFLAVE"], "active_ingredients": ["MAGNESIUM SULFATE", "POLYETHYLENE GLYCOL 3350", "POTASSIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230615", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026